Shares of HIMS experienced a dramatic decline today following the unexpected termination of its agreement with pharmaceutical giant Novo Nordisk. Investors reacted negatively to the news, sending its stock price plummeting by over 10%. The reason for the collapse of the partnership remains unclear, but industry analysts speculate that it could be r